Infectious disease test kit R061T016B0C1

pneumoniafor medical researchfor genes

Mycoplasma Pneumoniae and Macrolides-Resistant Strain Nucleic Acid Test Kit This kit is intended to detect Mycoplasma pneumonia and Macrolides-resistant (MR) mutation sites of 23S rRNA 2063 (A>G) and 2064 (A>G) in children's sputum samples qualitatively. Mycoplasma pneumonia causes mycoplasma pneumonia, upper respiratory tract infection, bronchitis, lung abscess, immune hemolytic anemia, meningitis, myocarditis, pericarditis, nephritis, community-acquired pneumonia, and other diseases. Macrolide antibiotics are the first-line drugs for the treatment of Mycoplasma pneumonia infection. The Macrolides-resistant strains have been isolated in clinical. The median duration of fever, hospital stay, and the median fever duration after macrolide therapy were significantly longer in the Macrolides-resistant patients than that in the Macrolides-sensitive (MS) patients.